Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.095 USD | -0.16% | -6.62% | -47.67% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.67% | 20.65M | |
+2.03% | 42.59B | |
+8.32% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.77% | 24.81B | |
-24.20% | 18.17B | |
+28.83% | 12.05B | |
-2.99% | 11.7B | |
+6.93% | 11.1B |
- Stock Market
- Equities
- MEIP Stock
- News MEI Pharma, Inc.
- MEI Pharma : Doses First Patient in Phase 3 Study of Zandelisib in Lymphoma Patients